Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2022-01-28 00:00:00 ET · period of report 2022-01-26 · accession 0001209191-22-005498 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-28 | 2022-01-26 | ADPT | Conroy Kevin T | Dir | A - Grant | $0.00 | +6,689 | 8,193 | +445% | $0 |
| D | 2022-01-28 | 2022-01-26 | ADPT | Conroy Kevin T | Dir | A - Grant | $0.00 | +16.7K | 16.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-26 | A | A | 6,689 | $0.00 | 8,193 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-26 | A | A | 16,722 | $0.00 | 16,722 | D | $14.95 · — to 2032-01-26 | 16,722 Common Stock | (F1) The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date. |